Cost-effectiveness of ribavirin interferon alfa-2B after interferon relapse in chronic hepatitis C.

被引：0
|
作者：
Wong, JB
Davis, GL
Pauker, SG
机构：
[1] Tufts New England Med Ctr, Div Clin Decis Making, Boston, MA USA
[2] Univ Florida, Dept Med, Sect Hepatobiliary Dis, Gainesville, FL USA
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1713
引用
收藏
页码：591A / 591A
页数：1
相关论文
共 50 条
  • [21] Consensus Interferon and Ribavirin in Patients with Chronic Hepatitis C Who Were Nonresponders to Pegylated Interferon alfa-2b and Ribavirin
    Carroll B. Leevy
    Digestive Diseases and Sciences, 2008, 53 : 1961 - 1966
  • [22] Consensus interferon and ribavirin in patients with chronic hepatitis c who were nonresponders to pegylated interferon alfa-2b and ribavirin
    Leevy, Carroll B.
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (07) : 1961 - 1966
  • [23] Cost-effectiveness of interferon/ribavirin treatment among nonresponders to initial interferon therapy for chronic hepatitis C.
    Kim, WR
    Poterucha, JJ
    Dickson, ER
    Gross, JB
    HEPATOLOGY, 1998, 28 (04) : 231A - 231A
  • [24] Consensus Interferon and Ribavirin in Patients with Chronic Hepatitis C Who Were Nonresponders to Pegylated Interferon alfa-2b and Ribavirin
    Carroll B. Leevy
    Digestive Diseases and Sciences, 2008, 53 (7) : 2009 - 2009
  • [25] Combination therapy with interferon alfa-2b, ribavirin, and amantadine in chronic hepatitis C non-responders to interferon and ribavirin
    Pande, H
    Thuluvath, PJ
    Jaffer, SA
    Maygers, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S96 - S96
  • [26] Interferon ALFA-2B (IFN-a2B)/ribavirin compared to consensus interferon (CIFN)/ribavirin in treatment of chronic hepatitis C
    Sjogren, MH
    Holtzmuller, K
    Sjogren, RW
    JOURNAL OF HEPATOLOGY, 2001, 34 : 234 - 234
  • [27] Impact of pegylated interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C.
    Poynard, T
    McHutchison, J
    Manns, M
    Trepo, C
    Lindsay, K
    Goodman, Z
    Ling, MS
    Albrecht, JK
    HEPATOLOGY, 2001, 34 (04) : 244A - 244A
  • [28] Cost-effectiveness of interferon treatment for chronic hepatitis C.
    Kareemi, M
    Peltekian, KM
    HEPATOLOGY, 1996, 24 (04) : 597 - 597
  • [29] Pegylated interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C genotype
    Hasan, F
    Asker, H
    Al-Khaldi, J
    Siddique, I
    Owaid, SF
    Al-Ajmi, M
    Al-Nakib, B
    HEPATOLOGY, 2003, 38 (04) : 629A - 629A
  • [30] Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
    McHutchison, JG
    Gordon, SC
    Schiff, ER
    Shiffman, ML
    Lee, WM
    Rustgi, VK
    Goodman, ZD
    Ling, MH
    Cort, S
    Albrecht, JK
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21): : 1485 - 1492
12345